Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Immune globulin 5% - SK Plasma

Next Previous
Drug Profile

Immune globulin 5% - SK Plasma

Alternative Names: LIV-GAMMA SN Inj; Liv-Gamma SN injection; LIV-GAMMA-SN; SKP-0100

Latest Information Update: 13 Sep 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator SK Plasma
  • Class Anti-infectives; Anti-inflammatories; Antibacterials; Antidementias; Antifibrotics; Antivirals; Eye disorder therapies; Immunoglobulins; Immunoproteins; Polyethylene glycols; Serum globulins; Skin disorder therapies; Vascular disorder therapies
  • Mechanism of Action Amyloid beta-protein inhibitors; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Agammaglobulinaemia; Guillain-Barre syndrome; Idiopathic thrombocytopenic purpura; Mucocutaneous lymph node syndrome
  • Phase II Bile duct diseases

Most Recent Events

  • 30 Aug 2024 SK Plasma terminates a phase-II trial in Bile duct diseases (Prevention) in South Korea (IV) due to change of clinical development plan (NCT05666453)
  • 07 Oct 2022 Phase-III development is ongoing in Idiopathic thrombocytopenic purpura in South Korea (IV) (NCT05566990)
  • 25 Apr 2022 Phase-II clinical trials in Bile duct diseases (Prevention, In adults, In the elderly) in South Korea (IV) (NCT05666453)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top